Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage

Diabetic cardiomyopathy as an important threat to health occurs with or without coexistence of vascular diseases. The exact mechanisms underlying the disease remain incompletely clear. Although several pathological mechanisms responsible for diabetic cardiomyopathy have been proposed, oxidative stre...

Full description

Saved in:
Bibliographic Details
Published inJournal of diabetes investigation Vol. 5; no. 6; pp. 623 - 634
Main Authors Liu, Quan, Wang, Shudong, Cai, Lu
Format Journal Article
LanguageEnglish
Published Japan Blackwell Publishing Ltd 01.11.2014
John Wiley & Sons, Inc
BlackWell Publishing Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Diabetic cardiomyopathy as an important threat to health occurs with or without coexistence of vascular diseases. The exact mechanisms underlying the disease remain incompletely clear. Although several pathological mechanisms responsible for diabetic cardiomyopathy have been proposed, oxidative stress is widely considered as one of the major causes for the pathogenesis of the disease. Hyperglycemia‐, hyperlipidemia‐, hypertension‐ and inflammation‐induced oxidative stress are major risk factors for the development of microvascular pathogenesis in the diabetic myocardium, which results in abnormal gene expression, altered signal transduction and the activation of pathways leading to programmed myocardial cell deaths. In the present article, we aim to provide an extensive review of the role of oxidative stress and anti‐oxidants in diabetic cardiomyopathy based on our own works and literature information available. Although several pathological mechanisms responsible for diabetic cardiomyopathy have been proposed, oxidative stress is widely considered as one of the major causes for the pathogenesis of the disease. Hyperglycemia‐, hyperlipidelima‐, hypertension‐, and inflammation‐induced oxidative stress is a major risk factor for the development of micro‐vascular pathogenesis in the diabetic myocardium, which results in abnormal gene expression, altered signal transduction, and the activation of pathways leading to programmed myocardial cell deaths.
Bibliography:ark:/67375/WNG-BXQ20P1T-C
ArticleID:JDI12250
istex:8DD48A6C9C25F4FF5C4D623F7026B83B1801DD51
American Diabetes Association - No. 05-07-CD-02; No. 1-11-BA-17
Development Program of Jilin Province Science and Technology Agency - No. 20130206048SF
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2040-1116
2040-1124
DOI:10.1111/jdi.12250